Antiphospholipid antibodies in children.

Area of Science:

• Hematology
• Immunology
• Clinical Medicine

Background:

• Lupus anticoagulant (LA) comprises heterogeneous IgG and IgM antibodies.
• LA prolongs clotting times in vitro and is linked to thrombosis and hemorrhage in vivo.
• Antiphospholipid antibodies (APAs) are found in various disorders or as isolated findings.

Purpose of the Study:

• To explore the mechanisms of action of LA and APAs.
• To understand the association of LA and anticardiolipin antibodies (ACAs) with thrombosis in adults and children.
• To investigate the thrombotic and hemorrhagic complications in children with LA and APAs.

Main Methods:

• Review of existing literature on LA and APAs.
• Analysis of clinical presentations in adult and pediatric populations.
• Exploration of antibody binding to protein phospholipid complexes as a unifying model.

Main Results:

• Thrombosis is a more common complication of LA than hemorrhage.
• A unifying model suggests antibody binding to protein phospholipid complexes.
• In children, LA-associated thrombosis can lead to acquired deficiencies of protein S, while hemorrhage can cause prothrombin deficiency.

Conclusions:

• The binding of APAs to protein phospholipid complexes provides a unifying model for their action.
• While the association of LA/ACAs with thrombosis is established in adults, predicting risk in asymptomatic individuals requires further research.
• Further research is needed to understand the epidemiology, mechanisms, and thrombotic potential of APAs in children to improve prevention and treatment of complications.